GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Copper Fox Metals Reports $1.2 Million Net Loss for 2025 and Advances Schaft Creek and Van Dyke Projects

by GOAI
Share To

Copper Fox Metals Inc. released its operating and financial results for the fiscal year ending December 31, 2025. The company reported a net loss of $1.2 million for the year, compared to a net loss of $1.4 million in 2024. Total expenses for the year amounted to $1.3 million, reflecting a slight decrease from $1.5 million in the previous year. Copper Fox also provided updates on its ongoing projects, including progress on its Schaft Creek and Van Dyke properties.

The company highlighted advancements in its exploration and development activities during 2025. At the Schaft Creek project, Copper Fox completed an updated resource model and initiated additional metallurgical testing to optimize project economics. Meanwhile, at the Van Dyke property, work focused on environmental baseline studies and permitting efforts to advance the project toward pre-feasibility status. The company stated that it remains committed to advancing these projects while managing costs effectively as part of its long-term strategy.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 5, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Ambarella to Present The Ambarella Edge Initiative on Physical AI at Embedded World 2026
2026-02-09
GXO Logistics to Manage Operations at BMW Group’s Swindon Site
2026-02-09
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09
TotalEnergies to Supply Google with 1 GW of Solar Energy for Texas Data Centers Over 15 Years
2026-02-09
TrumpRx Enters Pharmaceutical Market as Novo Nordisk Plans Super Bowl Ad for Oral Wegovy
2026-02-09
VHH Antibodies Derived from Camelids Show Potential for Targeted Therapies Despite Stability Challenges
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top